Scientists still don’t know why some people get Alzheimer’s and others can recall facts and memories well into their 90s, but they believe it’s…
Most of us have experienced the beginnings of a phone scam: that stern-sounding voicemail alerting you to call the IRS immediately, the confident reassurance…
Garlic’s list of health benefits is long; it’s naturally antimicrobial and can help fight infections, it has anti-inflammatory properties and studies suggest it helps…
As we age, our memory inevitably falters—it’s a normal sign of aging. But wouldn’t it be nice if you could return to the memory…
We know that regular brushing and keeping up with oral hygiene can save our teeth. But can it help preserve memory, too? A new…
Previous evidence that Alzheimer’s could be prevented with an over-the-counter anti-inflammatory drug like Aspirin was refuted by a new study. Researchers have long known…
It hasn’t been a great year for Alzheimer’s drugs—or really a great decade, even. The most recent Phase 3 trial cancellation was a study…
New research shows that heavy drinking is linked with structural changes in the brain during early abstinence. While research shows that there are many…
An under-utilized tool could help correctly diagnose and manage dementia, leading to better care, according to the 2019 IDEAS study. Published in the Journal…
Scientists have found something troubling off the coasts of Florida and Massachusetts: The brains of beached dolphins are showing signs of beta-amyloid, the protein…
Gloria Brown didn’t get a good night’s sleep. Her husband, Arthur Brown, 79, has Alzheimer’s disease and had spent most of the night pacing…
Women who spend less time in their reproductive years—those who get their period later, start menopause early or have a hysterectomy—may have a greater…
On Thursday, Biogen, along with its Japanese partner Eisai, announced it would be canceling two late-stage trials testing their drug aducanumab. The drug was…
Jeff Borghoff and his wife Kimberly speak about participating in the Biogen drug trial testing aducanumab, a drug that targets beta-amyloid. The late-stage trial…
Clinical trial participants, researchers and investors were reeling on Thursday after Biogen and Eisai, its Japanese pharmaceutical partner, announced that they would be halting two…